Publication | Open Access
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis
22
Citations
30
References
2021
Year
This study provides Class I evidence that for patients with PPMS, dimethyl fumarate treatment has no effect on CSF NFL levels compared with placebo treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1